Total Funding
83
70
Total FundingVenture - Series Unknown raised
Growth Score
-5 pts
Heat Score
-5 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
398913
Prognomix is a private research-based company focused on the discovery of genetic signatures associated with Type II Diabetes.
About the Company
Prognomix is a private research-based company focused on the discovery of genetic signatures associated with the complications of Type II Diabetes. The company plans to develop and market molecular diagnostic kits for the testing of diabetes complications. The company is concentrating on developing a molecular diagnostic test pertinent for
detection of risks to develop renal, ocular, cardiac, cerebral, vascular and other complications of diabetic disease. This market is vast and estimated to be around $24 billion in the United States alone.
